Trayectoria de vida familiar, transformaciones en el vínculo parento filial de tres personas mayores institucionalizadas y sus hijos (as) en Bogotá

This social research is mainly a study oriented by systemic thinking, which seeks to understand the transformations of the parental filial link in institutionalized older people and their sons and daughters from the analysis of the family life trajectory. The life stories are presented through the use of the Case Study and with it the construction of the parental filial link within the institutionalization process of the elderly and their children. In this perspective, there are life stories of three institutionalized elderly people or with experience in the institutional environment in the city of Bogotá, in order to know the dynamics, ruptures and factors that unite or distance the family. Therefore, the present study allows us to understand the context and reflections of older people and their children in terms of family interaction processes.Esta investigación social se constituye principalmente en un estudio orientado por el pensamiento sistémico, el cual busca comprender las transformaciones del vínculo parento filial en personas mayores institucionalizadas y sus hijos e hijas a partir del análisis de la trayectoria de vida familiar. Se presentan los relatos de vida a través del uso del Estudio de Caso y con ello la construcción del vínculo parento filial dentro del proceso de institucionalización de las personas mayores y sus hijos(as). En esta perspectiva se cuenta con los relatos de vida de tres personas mayores institucionalizados o con experiencia en el medio institucional en la ciudad de Bogotá, con el fin de conocer las dinámicas, rupturas y factores que unen o distancian a la familia. Por lo tanto, el presente estudio permite comprender el contexto y reflexiones de las personas mayores y sus hijos(as) en cuanto a los procesos de interacción familiar.Línea de Investigación: Familias y procesos sociales.Maestrí

Evaluation of strontium-containing hydroxyapatite as bone substitute in sheep tibiae.

With the advancement of research in biomaterials, it has been suggested that the best osteoconductivity of hydroxyapatite would be achieved if its crystal were closer to the structure, size and morphology of biological apatite, that is why nano-hydroxyapatite (nano-HA) is of great importance. current interest. Strontium ions are known to reduce bone resorption, induce osteoblastic activity and stimulate bone formation. The aim of this study was to evaluate biocompatibility and osteoconduction in surgical defects filled with nano-hydroxyapatite microspheres containing 1% strontium (nano-SrHA), stoichiometric nano-HA microspheres (nano-HA) compared to the clot (control) . Four Santa Inês sheep, weighing an average of 32 kg, were anesthetized and submitted to three 2 mm diameter perforations in the medial face of the tibia. The surgical defects were filled with blood clot, microspheres of Sr-HA 1% and microspheres of HA. After 30 days the samples were drawn (6 mm), decalcified, processed for inclusion in paraffin and stained with hematoxylin and eosin (HE) for histological evaluation with light microscopy. All groups revealed bone neoformation from the periphery to the center of the defect, with the nano-SrHA group being less intense among those studied. Presence of a discrete mononuclear inflammatory infiltrate in all experimental groups. Giant foreign body cells were only observed in the HA group. Areas of bone neoformation were observed in close contact with both biomaterials. According to the results obtained, microspheres of HA and SrHA 1% are biocompatible and have osteoconductive properties.With the advancement of research in biomaterials, it has been suggested that the best osteoconductivity of hydroxyapatite would be achieved if its crystal were closer to the structure, size and morphology of biological apatite, that is why nano-hydroxyapatite (nano-HA) is of great importance. current interest. Strontium ions are known to reduce bone resorption, induce osteoblastic activity and stimulate bone formation. The aim of this study was to evaluate biocompatibility and osteoconduction in surgical defects filled with nano-hydroxyapatite microspheres containing 1% strontium (nano-SrHA), stoichiometric nano-HA microspheres (nano-HA) compared to the clot (control) . Four Santa Inês sheep, weighing an average of 32 kg, were anesthetized and submitted to three 2 mm diameter perforations in the medial face of the tibia. The surgical defects were filled with blood clot, microspheres of Sr-HA 1% and microspheres of HA. After 30 days the samples were drawn (6 mm), decalcified, processed for inclusion in paraffin and stained with hematoxylin and eosin (HE) for histological evaluation with light microscopy. All groups revealed bone neoformation from the periphery to the center of the defect, with the nano-SrHA group being less intense among those studied. Presence of a discrete mononuclear inflammatory infiltrate in all experimental groups. Giant foreign body cells were only observed in the HA group. Areas of bone neoformation were observed in close contact with both biomaterials. According to the results obtained, microspheres of HA and SrHA 1% are biocompatible and have osteoconductive properties

Sistematización de la experiencia de acompañamiento en la pastoral de la ancianidad diócesis de Engativá “hacia un trabajo social gerontológico, como un proceso socioeducativo”

El presente documento evidencia en un primer momento un Trabajo Social Gerontológico enmarcado en la promoción de una vejez digna y saludable y la prevención de un envejecimiento patológico, desde la experiencia vivida en la práctica profesional en la pastoral de la ancianidad, en un segundo momento se dará una propuesta entorno a la ambigua interacción con las personas mayores direccionado su acción hacia un Trabajo Social Gerontológico como proceso socioeducativo en una relación sujeto – sujeto realizando procesos desde, con y para las personas mayores, reflexionando este accionar como un hecho de reconocimiento hacia el otro

Sistematización de la experiencia de acompañamiento en la pastoral de la ancianidad diócesis de Engativá “hacia un trabajo social gerontológico, como un proceso socioeducativo”

El presente documento evidencia en un primer momento un Trabajo Social Gerontológico enmarcado en la promoción de una vejez digna y saludable y la prevención de un envejecimiento patológico, desde la experiencia vivida en la práctica profesional en la pastoral de la ancianidad, en un segundo momento se dará una propuesta entorno a la ambigua interacción con las personas mayores direccionado su acción hacia un Trabajo Social Gerontológico como proceso socioeducativo en una relación sujeto – sujeto realizando procesos desde, con y para las personas mayores, reflexionando este accionar como un hecho de reconocimiento hacia el otro

Effect of Different Root Canal Irrigant Solutions on the Release of Dentin-Growth Factors: A Systematic Review and Meta-Analysis

From MDPI via Jisc Publications RouterHistory: accepted 2021-09-29, pub-electronic 2021-10-05Publication status: PublishedIrrigant solutions are used to promote dentin-growth factors (GF) release for regenerative endodontics. This review aimed to evaluate the reports comparing the release of GFs using different root canal irrigant solutions. Eligible studies compared the in vitro GF release in human teeth after the use of at least two distinct solutions. A search was conducted on Pubmed, Scopus, Web of Science, and Lilacs on 11 August 2021. Risk of bias was assessed using SciRAP. Study characteristics and quantitative data were extracted, and meta-analyses were performed for the mean difference (95% confidence interval) of the release of transforming growth factors Beta 1 (TGF-β1) by EDTA compared to other irrigants. Of sixteen eligible studies, eight were included in quantitative analysis. ELISA assays showed higher TGF-β1 release from 10% EDTA compared to 10% citric acid (p 0.00001). Immunogold assays showed higher levels of TGF-β1 for 17% EDTA (p 0.00001) compared to 10% citric acid. GRADE identified a low to very low certainty of evidence. These results point to an increased release of TGF-β1 in dentin treated with EDTA. The high heterogeneity and very low certainty of the evidence demand further studies before EDTA indication as a better irrigant for regenerative endodontics. Registration: CRD42020160871 (PROSPERO)

Curso de especialización: Narratología y Narrativa de posguerra

En la presente investigación es el resultado del análisis narrativo de la novela Ciudad de Alado de Mauricio Ernesto Orellana Suárez, por medio del proceso de deconstrucción de la realidad, Fernando Gómez Redondo apoya con su teoría práctica, a través, de las tres instancias narrativas: historia, narración y relato procedente de la ficcionalidad y apoyado por el Lenguaje literario, lo cual nos permite evidenciar el discurso narrativo dentro de la novela. Intervienen otros puntos importantes fundamentales para entender la novela Ciudad de Alado, es decir, todo lo que engloba la instancia narrativa: Mediante la teoría se defines los ejemplos textuales, extraídos de cada uno de los capítulos de la obra, elementos tales como: El estilo, movimiento literario, género, trama, personajes, voz, modo, tiempo entre otros; por otro lado se aplican las categorías de la posguerra, el contexto de la novela en estudio, la intención del autor todo ello ayuda para una mayor comprensión del análisis narratológico de la novela en estudio. Palabras Claves: Instancia de la Narración ; Instancia del Relato ; Instancia de la Historia ; Ficcionalidad ; Novela de Posguerra

Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis

Several psychotropic drugs, including antidepressants (AD), mood stabilizers, and antipsychotics (AP) have been suggested to have favorable effects in the treatment of COVID-19. The aim of this systematic review and meta-analysis was to collect evidence from studies concerning the scientific evidence for the repurposing of psychotropic drugs in COVID-19 treatment. Two independent authors searched PubMed-MEDLINE, Scopus, PsycINFO, and ClinicalTrials.gov databases, and reviewed the reference lists of articles for eligible articles published up to 13th December, 2021. All computational, preclinical and clinical (observational and/or RCTs) studies on the effect of any psychotropic drug on Sars-CoV-2 or patients with COVID-19 were considered for inclusion. We conducted random effect meta-analyses on clinical studies reporting the effect of AD or AP on COVID-19 outcomes. 29 studies were included in the synthesis: 15 clinical, 9 preclinical, and 5 computational studies. 9 clinical studies could be included in the quantitative analyses. AD did not increase the risk of severe COVID-19 (RR= 1.71; CI 0.65-4.51) or mortality (RR=0.94; CI 0.81-1.09). Fluvoxamine was associated with a reduced risk of mortality for COVID-19 (OR=0.15; CI 0.02-0.95). AP increased the risk of severe COVID-19 (RR=3.66; CI 2.76-4.85) and mortality (OR=1.53; CI 1.15-2.03). Fluvoxamine might be a possible candidate for psychotropic drug repurposing in COVID-19 due to its anti-inflammatory and antiviral potential, while evidence on other AD is still controversial. Although AP are associated with worse COVID-19 outcomes, their use should be evaluated case to case and ongoing treatment with antipsychotics should be not discontinued in psychiatric patients

Psychotropic drug repurposing for COVID-19: a Systematic Review and Meta-Analysis

Several psychotropic drugs, including antidepressants (AD), mood stabilizers, and antipsychotics (AP) have been suggested to have favorable effects in the treatment of COVID-19. The aim of this systematic review and meta-analysis was to collect evidence from studies concerning the scientific evidence for the repurposing of psychotropic drugs in COVID-19 treatment. Two independent authors searched PubMed-MEDLINE, Scopus, PsycINFO, and ClinicalTrials.gov databases, and reviewed the reference lists of articles for eligible articles published up to 13th December, 2021. All computational, preclinical and clinical (observational and/or RCTs) studies on the effect of any psychotropic drug on Sars-CoV-2 or patients with COVID-19 were considered for inclusion. We conducted random effect meta-analyses on clinical studies reporting the effect of AD or AP on COVID-19 outcomes. 29 studies were included in the synthesis: 15 clinical, 9 preclinical, and 5 computational studies. 9 clinical studies could be included in the quantitative analyses. AD did not increase the risk of severe COVID-19 (RR= 1.71; CI 0.65-4.51) or mortality (RR=0.94; CI 0.81-1.09). Fluvoxamine was associated with a reduced risk of mortality for COVID-19 (OR=0.15; CI 0.02-0.95). AP increased the risk of severe COVID-19 (RR=3.66; CI 2.76-4.85) and mortality (OR=1.53; CI 1.15-2.03). Fluvoxamine might be a possible candidate for psychotropic drug repurposing in COVID-19 due to its anti-inflammatory and antiviral potential, while evidence on other AD is still controversial. Although AP are associated with worse COVID-19 outcomes, their use should be evaluated case to case and ongoing treatment with antipsychotics should be not discontinued in psychiatric patients

Depression prevalence using the HADS-D compared to SCID major depression classification:An individual participant data meta-analysis

Objectives: Validated diagnostic interviews are required to classify depression status and estimate prevalence of disorder, but screening tools are often used instead. We used individual participant data meta-analysis to compare prevalence based on standard Hospital Anxiety and Depression Scale – depression subscale (HADS-D) cutoffs of ≥8 and ≥11 versus Structured Clinical Interview for DSM (SCID) major depression and determined if an alternative HADS-D cutoff could more accurately estimate prevalence. Methods: We searched Medline, Medline In-Process & Other Non-Indexed Citations via Ovid, PsycINFO, and Web of Science (inception-July 11, 2016) for studies comparing HADS-D scores to SCID major depression status. Pooled prevalence and pooled differences in prevalence for HADS-D cutoffs versus SCID major depression were estimated. Results: 6005 participants (689 SCID major depression cases) from 41 primary studies were included. Pooled prevalence was 24.5% (95% Confidence Interval (CI): 20.5%, 29.0%) for HADS-D ≥8, 10.7% (95% CI: 8.3%, 13.8%) for HADS-D ≥11, and 11.6% (95% CI: 9.2%, 14.6%) for SCID major depression. HADS-D ≥11 was closest to SCID major depression prevalence, but the 95% prediction interval for the difference that could be expected for HADS-D ≥11 versus SCID in a new study was −21.1% to 19.5%. Conclusions: HADS-D ≥8 substantially overestimates depression prevalence. Of all possible cutoff thresholds, HADS-D ≥11 was closest to the SCID, but there was substantial heterogeneity in the difference between HADS-D ≥11 and SCID-based estimates. HADS-D should not be used as a substitute for a validated diagnostic interview.This study was funded by the Canadian Institutes of Health Research (CIHR, KRS-144045 & PCG 155468). Ms. Neupane was supported by a G.R. Caverhill Fellowship from the Faculty of Medicine, McGill University. Drs. Levis and Wu were supported by Fonds de recherche du Québec - Santé (FRQS) Postdoctoral Training Fellowships. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions. The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust, and funding from the Hotchkiss Brain Institute. The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine, and the Hotchkiss Brain Institute. The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland, the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund. The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association. The primary study by De Souza et al. was supported by Birmingham and Solihull Mental Health Foundation Trust. The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada. The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research (01GY1150). The primary study by Gagnon et al. was supported by the Drummond Foundation and the Department of Psychiatry, University Health Network. The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11−2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9–31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000). The primary study by Love et al. (2004) was supported by the Kathleen Cuningham Foundation (National Breast Cancer Foundation), the Cancer Council of Victoria and the National Health and Medical Research Council. The primary study by Love et al. (2002) was supported by a grant from the Bethlehem Griffiths Research Foundation. The primary study by Löwe et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by the Spanish grants from the Fondo de Investigación en Salud, Instituto de Salud Carlos III (EO PI08/90869 and PSIGEN-VHC Study: FIS-E08/00268) and the support of FEDER (one way to make Europe). The primary study by O'Rourke et al. was supported by the Scottish Home and Health Department, Stroke Association, and Medical Research Council. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain (PI040418) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund. The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundaçao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM). The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance, as well as a studentship from the Canadian Institutes of Health Research. The primary study by Singer et al. (2009) was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106). The primary study by Singer et al. (2008) was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX) and of the University of Leipzig (# formel. 1–57). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF). The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland. The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute. The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards. No other authors reported funding for primary studies or for their work on this study. No funder had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication